SCHEMBL23725339

SCHEMBL23725339

O=Cc1ccc2c(=O)n(-c3cccc(Br)c3)cnc2c1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
FGFR1 P11362 1/20 0.52
ESR1 P03372 2/20 0.45
ESR2 Q92731 2/20 0.45
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MGLL Q99685 1/20 0.36
PDE4A P27815 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2649006 0.83 FGFR1 (0.67) MEN1KMT2AFGFR1ALDH1A1
SCHEMBL7668310 0.82 MEN1 (0.71) MEN1KMT2AFGFR1ESR1ESR2
SCHEMBL15652353 0.80 FGFR1 (0.52) MEN1KMT2AFGFR1ESR1ESR2
SCHEMBL23724972 0.79 MEN1 (0.67) MEN1KMT2AFGFR1ESR1ESR2
SCHEMBL23725318 0.77 MEN1 (0.40) MEN1KMT2AFGFR1ESR1ESR2
SCHEMBL12415699 0.74 FGFR1 (0.54) MEN1KMT2AFGFR1ALDH1A1
SCHEMBL28738321 0.74 ESR1 (0.63) MEN1KMT2AESR1ESR2ALDH1A1
SCHEMBL23725281 0.72 MEN1 (0.57) MEN1KMT2AFGFR1ESR1ESR2
SCHEMBL24320737 0.71 ACVR1 (0.46) MEN1KMT2AFGFR1ESR1ESR2
SCHEMBL14851885 0.69 FGFR1 (0.58) MEN1KMT2AFGFR1ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 CN disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL MEN1 896/4885KMT2A 346/4885FGFR1 1920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.